(Q59789486)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

title

p53 regulates CD46 expression and measles virus infection in myeloma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Sophie Barillé-Nion

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Agnes Moreau-Aubry

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

15

Philippe Moreau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

author name string

Anne Lok

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Geraldine Descamps

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Benoit Tessoulin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

David Chiron

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Marion Eveillard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Catherine Godon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Yannick Le Bris

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Celine Bellanger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Laurent Maillet

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Marc Gregoire

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Jean-François Fonteneau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Steven Le Gouill

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Frederic Tangy

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Martine Amiot

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Catherine Pellat-Deceunynck

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

language of work or name

English

0 references

publication date

1 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

page(s)

3492-3505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

Regression of Burkitt's lymphoma in association with measles infection.

13 April 2020

cites work

1 reference

12 December 2020

CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus

1 reference

12 December 2020

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

1 reference

12 December 2020

A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice

1 reference

12 December 2020

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

1 reference

12 December 2020

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

1 reference

12 December 2020

Oncolytic measles virus targets high CD46 expression on multiple myeloma cells

1 reference

12 December 2020

Naturally oncolytic viruses.

1 reference

12 December 2020

Interferon, a growing cytokine family: 50 years of interferon research

1 reference

12 December 2020

Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.

1 reference

12 December 2020

Resistance to viral infection of super p53 mice.

1 reference

12 December 2020

Measles virus for cancer therapy

1 reference

12 December 2020

Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cells

1 reference

12 December 2020

Cancer resistance to complement-dependent cytotoxicity (CDC): Problem-oriented research and development

1 reference

12 December 2020

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma

1 reference

12 December 2020

Therapeutic potential of oncolytic measles virus: promises and challenges

1 reference

12 December 2020

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines

1 reference

12 December 2020

The peripheral CD138+ population but not the CD138− population contains myeloma clonogenic cells in plasma cell leukaemia patients

1 reference

12 December 2020

HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF-κB signaling to protect breast cancer cells from complement attack.

1 reference

12 December 2020

Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells.

1 reference

12 December 2020

Oncolytic virotherapy

1 reference

12 December 2020

MicroRNAs in the p53 network: micromanagement of tumour suppression

1 reference

12 December 2020

p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs

1 reference

12 December 2020

Rapid molecular diagnosis of measles virus infection in an epidemic setting.

1 reference

12 December 2020

The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses

1 reference

12 December 2020

Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other.

1 reference

12 December 2020

Remission of disseminated cancer after systemic oncolytic virotherapy

1 reference

12 December 2020

The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack

1 reference

12 December 2020

RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53abnormal myeloma cells independently of the p53 pathway.

1 reference

12 December 2020

PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance.

1 reference

12 December 2020

A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.

1 reference

12 December 2020

The Nectin-4/Afadin Protein Complex and Intercellular Membrane Pores Contribute to Rapid Spread of Measles Virus in Primary Human Airway Epithelia

1 reference

12 December 2020

HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response

1 reference

12 December 2020

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

1 reference

12 December 2020

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.

1 reference

12 December 2020

CRISPR-Cas9-based target validation for p53-reactivating model compounds.

1 reference

12 December 2020

Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.

1 reference

12 December 2020

BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma.

1 reference

12 December 2020

MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors

1 reference

12 December 2020

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.

1 reference

12 December 2020

Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells

1 reference

12 December 2020

p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell.

1 reference

12 December 2020

Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53 accumulation

1 reference

12 December 2020

Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma

1 reference

12 December 2020

Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity

1 reference

12 December 2020

Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy.

1 reference

12 December 2020

DNA repair processes are critical mediators of p53-dependent tumor suppression

1 reference

12 December 2020

10.1182/BLOODADVANCES.2018025106

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30530776%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference